维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

14篇 您的检索式：作者名="Odenike"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Emerging role of the histone deacetylase inhibitor romidepsin in hematologic malignancies 显示文摘	lain N Odenike O	2010	Expert Opin Phanmwother2010，11，18：	1
	2	Late-phase investigational approaches for the treatment of relapsed/refractory acute myeloid leukemia显示文摘	Jamieson K Odenike O	2012	Expert Opin Pharmacother2012，13，15：	1
	3	Dose-ranging pharmacodynamic study of tipifarnib (Rl15777) in patients with relapsed and refractory hematologic malignancies 显示文摘	ZIMMERMAN T M HARLIN H ODENIKE OM	2004	J Clin Oncol2004，22，：	1
	4	Leukaemogenesis: more than mutant genes显示文摘	Chen J Odenike O Rowley JD	2010	Nat Rev Cancer2010，10，1：	1
	5	Conventional and new treatment options for myelofibrosis with myeloid metaplasia显示文摘	Odenike O Tefferi A	2005	Sem Oncol2005，32，：	1
	6	Histone deacetylase inhibitor romidepsin has differential activity in core bin- ding factor acute myeloid leukemia 显示文摘	Odenike OM Alkan S Sher D	2008	Clin Cancer Res2008，14，21：	1
	7	Beyond JAK inhibitor therapy in myelofibrosis显示文摘	Odenike O	2013	Am Soc Hematol Educ Program2013，2013，：	1
	8	PhaseⅠdose-escalation trial of SB1518,a novel JAK2/FLT3inhibitor,in acute and chronic myeloid diseases,including primary or post-essential thrombocythemia polycythemia vera myelofibrosis显示文摘	VERSTOVSEK S ODENIKE O SCOTT B	2009	Blood2009，114，：	1
	9	A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance)显示文摘	Pankaj Gupta Flora Mulkey Robert P. Hasserjian Ben L. Sanford Ravi Vij David D. Hurd Olatoyosi M. Odenike Clara D. Bloomfield Kouros Owzar Richard M. Stone Richard A. Larson	2013	Investigational New Drugs2013，，：	1
	10	Defining and treating older adults with acute myeloid leukemia who are ineligible for intensive therapies显示文摘	Pettit K Odenike O	2015	Front Oncol2015，5，：	1
	11	Leukacmogenesis: more than mutant genes 显示文摘	Chen J Odenike O Rowley JD	2010	Nat Rev Cancer2010，10，1：	1
	12	A method for calculation of true coincidence summing correction factors for extended sources 显示文摘	Tim Vidmar Matjaz Korun Branko ~odenik	2007	Applied Radiation and Isotopes2007，65，：	1
	13	Dose - ranging pharmacodynamic study of R115777 in patients with refractory hematologic malignancies 显示文摘	Harlin H Odenike T	2003	Proc Am Soc Clin Oncol2003，22，：	1
	14	Doseranging parmacodynamic study of tiptfarnib in patients with relapsed and refractory hematologic malignancies显示文摘	Zimmerman TM Harlin H Odenike OM	2004	J Clin Oncol2004，22，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费